Haruhiko Kamada

6.1k total citations
140 papers, 3.8k citations indexed

About

Haruhiko Kamada is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Haruhiko Kamada has authored 140 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 43 papers in Immunology and 35 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Haruhiko Kamada's work include Monoclonal and Polyclonal Antibodies Research (34 papers), Immunotherapy and Immune Responses (18 papers) and Immune Response and Inflammation (17 papers). Haruhiko Kamada is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (34 papers), Immunotherapy and Immune Responses (18 papers) and Immune Response and Inflammation (17 papers). Haruhiko Kamada collaborates with scholars based in Japan, United States and Switzerland. Haruhiko Kamada's co-authors include Yasuo Tsutsumi, Shin‐ichi Tsunoda, Yasuo Yoshioka, Kazuya Nagano, Yasuhiro Abe, Tadanori Mayumi, Yohei Mukai, Shinsaku Nakagawa, Tomoaki Yoshikawa and Hiromi Nabeshi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Haruhiko Kamada

134 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruhiko Kamada Japan 38 1.6k 756 670 570 566 140 3.8k
Shin‐ichi Tsunoda Japan 41 2.0k 1.3× 952 1.3× 1.0k 1.5× 717 1.3× 619 1.1× 194 4.9k
Oleg Lunov Czechia 35 1.1k 0.7× 815 1.1× 616 0.9× 890 1.6× 824 1.5× 77 4.0k
Yasuo Yoshioka Japan 32 934 0.6× 586 0.8× 849 1.3× 556 1.0× 401 0.7× 97 2.8k
Kazuya Nagano Japan 30 1.4k 0.9× 431 0.6× 719 1.1× 443 0.8× 320 0.6× 101 3.3k
Hyewon Youn South Korea 30 1.6k 1.0× 298 0.4× 298 0.4× 1.0k 1.8× 466 0.8× 108 3.6k
Rama Shanker Verma India 35 1.7k 1.1× 453 0.6× 233 0.3× 785 1.4× 713 1.3× 209 4.4k
Yongping Su China 34 1.9k 1.2× 367 0.5× 909 1.4× 1.7k 3.0× 696 1.2× 141 5.4k
Naoki Utoguchi Japan 28 1.2k 0.8× 264 0.3× 436 0.7× 871 1.5× 381 0.7× 85 3.0k
Liangliang Wang China 32 1.9k 1.2× 581 0.8× 326 0.5× 653 1.1× 218 0.4× 141 4.0k
Melpo Christofidou‐Solomidou United States 45 2.1k 1.3× 779 1.0× 144 0.2× 291 0.5× 434 0.8× 110 5.3k

Countries citing papers authored by Haruhiko Kamada

Since Specialization
Citations

This map shows the geographic impact of Haruhiko Kamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Kamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Kamada more than expected).

Fields of papers citing papers by Haruhiko Kamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruhiko Kamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Kamada. The network helps show where Haruhiko Kamada may publish in the future.

Co-authorship network of co-authors of Haruhiko Kamada

This figure shows the co-authorship network connecting the top 25 collaborators of Haruhiko Kamada. A scholar is included among the top collaborators of Haruhiko Kamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruhiko Kamada. Haruhiko Kamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Furukawa, Kentaro, Tomoko Ise, Masahiro Takayama, et al.. (2024). Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo. PLoS ONE. 19(12). e0300297–e0300297. 2 indexed citations
4.
Akiba, Hiroki, et al.. (2023). A Proximity‐Induced Fluorogenic Reaction Triggered by Antibody–Antigen Interactions with Adjacent Epitopes. Angewandte Chemie International Edition. 62(30). e202306431–e202306431. 5 indexed citations
5.
Kato, Daiki, Tomonori Yaguchi, Takashi Iwata, et al.. (2020). GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab. eLife. 9. 47 indexed citations
6.
Inoue, Masaki, Haruhiko Kamada, Yohei Mukai, et al.. (2017). A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification. Journal of Biological Chemistry. 292(16). 6438–6451. 13 indexed citations
7.
Nagano, Kazuya, Yuka Maeda, Takuya Yamashita, et al.. (2014). Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers. Journal of Controlled Release. 189. 72–79. 41 indexed citations
8.
Yoshida, Tokuyuki, Yasuo Yoshioka, Keigo Matsuyama, et al.. (2012). Surface modification of amorphous nanosilica particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA damage in various mammalian cells. Biochemical and Biophysical Research Communications. 427(4). 748–752. 44 indexed citations
9.
Imai, Sunao, Kazuya Nagano, Takuya Yamashita, et al.. (2010). Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteins. Biomaterials. 32(1). 162–169. 25 indexed citations
10.
Sugita, Takahisa, T. Yoshikawa, Yohei Mukai, et al.. (2008). Comparative study on transduction and toxicity of protein transduction domains. British Journal of Pharmacology. 153(6). 1143–1152. 56 indexed citations
11.
Abe, Yasuhiro, Tomoaki Yoshikawa, Haruhiko Kamada, et al.. (2008). Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activity. Journal of Immunological Methods. 335(1-2). 71–78. 11 indexed citations
12.
Hayashi, Tatsuya, Junji Nishioka, Naoya Nakagawa, et al.. (2007). Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator. Journal of Thrombosis and Haemostasis. 5(7). 1477–1485. 19 indexed citations
13.
Hamada, Tetsuya, Haruhiko Kamada, Takio HAYASHI, et al.. (2007). Protein C inhibitor regulates hepatocyte growth factor activator-mediated liver regeneration in mice. Gut. 57(3). 365–373. 10 indexed citations
14.
Okamoto, Takayuki, Yohei Mukai, Yasuo Yoshioka, et al.. (2004). Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen. Biochemical and Biophysical Research Communications. 323(2). 583–591. 33 indexed citations
15.
Suzuki, Koji, Esteban C. Gabazza, Tatsuya Hayashi, et al.. (2004). Protective role of activated protein C in lung and airway remodeling. Critical Care Medicine. 32(Supplement). S262–S265. 29 indexed citations
16.
Yoshioka, Yasuo, Yasuo Tsutsumi, Yohei Mukai, et al.. (2004). Effective accumulation of poly(vinylpyrrolidone‐co‐vinyl laurate) into the spleen. Journal of Biomedical Materials Research Part A. 70A(2). 219–223. 11 indexed citations
17.
Kodaira, Hiroshi, Yasuo Tsutsumi, Yasuo Yoshioka, et al.. (2003). The targeting of anionized polyvinylpyrrolidone to the renal system. Biomaterials. 25(18). 4309–4315. 57 indexed citations
18.
Tsutsumi, Yasuo, Shin‐ichi Tsunoda, Haruhiko Kamada, et al.. (1996). Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency. British Journal of Cancer. 74(7). 1090–1095. 36 indexed citations
19.
Tsutsumi, Yasuo, Shin‐ichi Tsunoda, Yoshihisa Kaneda, et al.. (1996). In vivo Anti‐tumor Efficacy of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α against Tumor Necrosis Factor‐resistant Tumors. Japanese Journal of Cancer Research. 87(10). 1078–1085. 11 indexed citations
20.
Tsunoda, Shin‐ichi, Tetsunari Kihira, Haruhiko Kamada, et al.. (1995). Characterization of PEG-IL-6 and its thrombopoietic activity in vivo.. Drug Delivery System. 10(3). 175–180. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin‐ichi Tsunoda Breakdown of academic impact, for papers by Oleg Lunov Breakdown of academic impact, for papers by Yasuo Yoshioka Breakdown of academic impact, for papers by Kazuya Nagano Breakdown of academic impact, for papers by Hyewon Youn Breakdown of academic impact, for papers by Rama Shanker Verma Breakdown of academic impact, for papers by Yongping Su Breakdown of academic impact, for papers by Naoki Utoguchi Breakdown of academic impact, for papers by Liangliang Wang Breakdown of academic impact, for papers by Melpo Christofidou‐Solomidou
Rankless by CCL
2026